Ticagrelor and Trospium / Xanomeline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Ticagrelor
Trospium / Xanomeline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed Brilinta (ticagrelor), a blood thinner that helps prevent clots, along with Cobenfy, which contains xanomeline. One ingredient in Cobenfy can briefly slow down a gut enzyme (called CYP3A4) that helps break down ticagrelor. When that enzyme is slowed, a bit more ticagrelor can be absorbed into your body.
In plain terms, this could make ticagrelor's effects a little stronger, which mainly means a slightly higher chance of bruising or bleeding. The good news is this is a theoretical concern, not something proven to cause big problems. Your care team can manage it easily by keeping an eye on you, so keep taking both as prescribed and share any unusual bleeding.
Mechanism: Xanomeline transiently inhibits intestinal CYP3A4 (not systemic). Ticagrelor is a sensitive oral CYP3A4 substrate, so co-administration may increase ticagrelor exposure (AUC/Cmax) via reduced gut first-pass metabolism.
Direction: Increased ticagrelor effect, raising antiplatelet-related bleeding risk. Ticagrelor is active itself (its metabolite is also active), so inhibition augments rather than blunts effect.
- Severity: Moderate; evidence: theoretical; onset: unspecified.
- Management: Monitor for increased frequency/severity of bleeding (bruising, epistaxis, GI bleeding). Dose may be individualized by the care team; consider closer clinical follow-up if used together.
What happens
Increased oral sensitive CYP3A4 substrate exposure and an increased risk on severity and frequency of sensitive CYP3A4 substrate-related adverse reactions
Interaction Deep Dive
Within the gut, xanomeline produces a temporary local inhibition of CYP3A4, though this effect does not extend systemically. When xanomeline is taken alongside oral medications that are sensitive substrates of CYP3A4, the exposure to those oral sensitive CYP3A4 substrates may rise. Such an increase can lead to a greater frequency and/or severity of adverse reactions associated with those substrates. In cases of concurrent use, patients should be monitored for any rise in the frequency and/or severity of adverse reactions linked to oral drugs that are sensitive substrates of CYP3A41.
Why it happens (mechanism)
Inhibition of CYP3A4-substrate metabolism by xanomeline
How to manage this interaction
This interaction can usually be managed with simple monitoring, so keep taking both medications exactly as prescribed unless your prescriber tells you otherwise.
- Your care team may watch you a bit more closely for signs the ticagrelor is having a stronger effect.
- Watch for unusual bruising, nosebleeds, bleeding gums, pink or red urine, black stools, or bleeding that won't stop, and report these promptly.
- Any dose changes should be individualized by your doctor or pharmacist, not made on your own.
Bring an updated medication list to appointments so your pharmacist can double-check everything works well together.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Ticagrelor and Trospium / Xanomeline together?
Cobenfy (xanomeline) may modestly increase ticagrelor levels by slowing its breakdown in the gut, slightly raising bleeding risk; this is a theoretical concern your care team can manage with monitoring, so keep taking both as prescribed and report any unusual bleeding. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Ticagrelor and Trospium / Xanomeline interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Ticagrelor and Trospium / Xanomeline interaction managed?
This interaction can usually be managed with simple monitoring, so keep taking both medications exactly as prescribed unless your prescriber tells you otherwise. Your care team may watch you a bit more closely for signs the ticagrelor is having a stronger effect. Watch for unusual bruising, nosebleeds, bleeding gums, pink or red urine, black stools, or bleeding that won't stop, and report these pr… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Ticagrelor or Trospium / Xanomeline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (1)
- Citation #1
Keep reading about Ticagrelor
Keep reading about Trospium / Xanomeline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist